Director Dealing

RNS Number : 5390O

Oakley Capital Investments Limited

10 February 2021

 

10 February 2021

Oakley Capital Investments Limited

Director Dealing

Oakley Capital Investments Limited¹ (the "Company"), was notified today of the following transaction by a Director of the Company:

Richard Lightowler, Director of the Company, has purchased 30,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at a price of 291.67 pence per Ordinary Share. As a result, Mr Lightowler is now interested in 130,000 Ordinary Shares of the Company, representing 0.072 percent of the issued share capital.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Richard Lightowler
2	Reason for the notification
a)	Position/status	Director
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Oakley Capital Investments Limited
b)	LEI	213800KW6MZUK12CQ815
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 1p each BMG670131058
b)	Nature of the transaction	Acquisition
c)	Price(s) and volume(s)	Price(s) Volume(s) 291.61 p 30,000
d)	Aggregated information -  Aggregated volume -  Price	N/A (single transaction)
e)	Date of the transaction	27 January 2021
f)	Place of the transaction	London Stock Exchange, Specialist Fund Segment

- ends -

For further information please contact:

Oakley Capital Limited

[phone]

Steven Tredget, Investor Relations

Greenbrook Communications Limited

[phone]

Alex Jones / Michael Russell / James Williams

Liberum Capital Limited (Financial Adviser & Broker)

[phone]

Gillian Martin / Owen Matthews

Notes:

LEI Number: 213800KW6MZUK12CQ815

¹  About Oakley Capital Investments Limited ("OCI")

OCI is a  Specialist Fund Segment ("SFS")  traded investment vehicle that aims to provide shareholders with consistent long-term capital growth in excess of the FTSE All-Share Index by providing liquid access to private equity returns through investment in the Oakley Funds ² .

A video introduction to OCI is available at  https://oakleycapitalinvestments.com/videos/

The contents of the OCI website are not incorporated into, and do not form part of, this announcement.

Oakley Capital, the Investment Adviser

Founded in 2002, Oakley Capital Limited has demonstrated the repeated ability to source attractive growth assets at attractive prices. To do this it relies on its sector and regional expertise, its ability to tackle transaction complexity and its deal generating entrepreneur network.

The Oakley Funds

Oakley Capital Private Equity L.P. and its successor funds, Oakley Capital Private Equity II, Oakley Capital Private Equity III, Oakley Capital IV and Oakley Capital Origin Fund are unlisted lower-mid to mid-market private equity funds that aim to provide investors with significant long-term capital appreciation. The investment strategy of the Funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement.

Important information

Specialist Fund Segment securities are not admitted to the Official List of the Financial Conduct Authority. Therefore, the Company has not been required to satisfy the eligibility criteria for admission to listing on the Official List and is not required to comply with the Financial Conduct Authority's Listing Rules.

The Specialist Fund Segment is intended for institutional, professional, professionally advised and knowledgeable investors who understand, or who have been advised of, the potential risk from investing in companies admitted to the Specialist Fund Segment.

 

END

 

 

DSHFKLLBFLLXBBK